A US study has shown that people with type 1 diabetes are more likely to develop dementia than the general population, highlighting the importance of following up on brain health as we age.
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
CamDiab announced today that it is introducing CamAPS Liberty, a fully closed-loop feature for its CamAPS FX app.
Sequel Med Tech today announced the broad availability of its twiist automated insulin delivery system in the U.S.
Erin Calhoun-Dulaney has transformed what was once a pain point in her Type 1 diabetes management into a business opportunity ...
Medtronic broadens its diabetes device portfolio with MiniMed Go Smart MDI system launch across Europe The integrated ...
The Food and Drug Administration on Tuesday posted a warning letter sent to Beta Bionics in late January. The letter raised concerns with how the diabetes tech company handled complaints of severe low ...
WESTFIELD, Ind., Feb. 17, 2026 /PRNewswire/ -- Today, Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug Administration (FDA) for its ...
Growing diabetes prevalence, with over 540 million diagnosed individuals worldwide, and the increasing adoption of continuous subcutaneous insulin infusion (CSII) therapy are fueling market demand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results